游离三碘甲状腺原氨酸和总三碘甲状腺原氨酸与非酒精性脂肪肝的关系:来自全国健康与营养调查和孟德尔随机化研究。

IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY
Wei Hao, Lanlan Chen, Ting Li, Guoyue Lv
{"title":"游离三碘甲状腺原氨酸和总三碘甲状腺原氨酸与非酒精性脂肪肝的关系:来自全国健康与营养调查和孟德尔随机化研究。","authors":"Wei Hao, Lanlan Chen, Ting Li, Guoyue Lv","doi":"10.1097/MEG.0000000000002963","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nonalcoholic fatty liver disease (NAFLD) is associated with multiple factors, yet the relationship between NAFLD and thyroid-related biomarkers remains unclear. This study aims to elucidate this potential linkage.</p><p><strong>Methods: </strong>Utilizing data from the US National Health and Nutrition Examination Survey (NHANES), we explored the possible associations between thyroid-related biomarkers and NAFLD through multivariable logistic regression, subgroup analysis, and interaction tests. A bidirectional Mendelian randomization (MR) approach complemented by various sensitivity analyses was then employed to ascertain these relationships' causality.</p><p><strong>Results: </strong>Our NHANES analysis indicated significant associations between elevated levels of free triiodothyronine (FT3) [odds ratio (OR): 2.59, 95% confidence interval (CI): 1.50-4.49] and total triiodothyronine (TT3) (OR: 2.01, 95% CI: 1.27-3.18) with the prevalence of NAFLD. MR findings reinforced the causal relationship, demonstrating that NAFLD may elevate FT3 ( β : 0.05, 95% CI: 0.01-0.09) and TT3 ( β : 0.08, 95% CI: 0.02-0.14) levels. Additionally, thyroid-stimulating hormone (TSH) was confirmed as an independent risk factor for NAFLD (OR: 1.10, 95% CI: 1.04-1.18), with specific MR sensitivity analyses supporting the robustness of these results.</p><p><strong>Conclusion: </strong>This study indicates potential elevations in FT3, TT3, and thyroglobulin levels associated with NAFLD, while also identifying TSH as a risk factor for NAFLD. These findings underscore the importance of routine thyroid function monitoring both in the general population and particularly in individuals with NAFLD.</p>","PeriodicalId":11999,"journal":{"name":"European Journal of Gastroenterology & Hepatology","volume":" ","pages":"864-874"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of free triiodothyronine and total triiodothyronine with nonalcoholic fatty liver disease: from National Health and Nutrition Examination Survey and Mendelian randomization study.\",\"authors\":\"Wei Hao, Lanlan Chen, Ting Li, Guoyue Lv\",\"doi\":\"10.1097/MEG.0000000000002963\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Nonalcoholic fatty liver disease (NAFLD) is associated with multiple factors, yet the relationship between NAFLD and thyroid-related biomarkers remains unclear. This study aims to elucidate this potential linkage.</p><p><strong>Methods: </strong>Utilizing data from the US National Health and Nutrition Examination Survey (NHANES), we explored the possible associations between thyroid-related biomarkers and NAFLD through multivariable logistic regression, subgroup analysis, and interaction tests. A bidirectional Mendelian randomization (MR) approach complemented by various sensitivity analyses was then employed to ascertain these relationships' causality.</p><p><strong>Results: </strong>Our NHANES analysis indicated significant associations between elevated levels of free triiodothyronine (FT3) [odds ratio (OR): 2.59, 95% confidence interval (CI): 1.50-4.49] and total triiodothyronine (TT3) (OR: 2.01, 95% CI: 1.27-3.18) with the prevalence of NAFLD. MR findings reinforced the causal relationship, demonstrating that NAFLD may elevate FT3 ( β : 0.05, 95% CI: 0.01-0.09) and TT3 ( β : 0.08, 95% CI: 0.02-0.14) levels. Additionally, thyroid-stimulating hormone (TSH) was confirmed as an independent risk factor for NAFLD (OR: 1.10, 95% CI: 1.04-1.18), with specific MR sensitivity analyses supporting the robustness of these results.</p><p><strong>Conclusion: </strong>This study indicates potential elevations in FT3, TT3, and thyroglobulin levels associated with NAFLD, while also identifying TSH as a risk factor for NAFLD. These findings underscore the importance of routine thyroid function monitoring both in the general population and particularly in individuals with NAFLD.</p>\",\"PeriodicalId\":11999,\"journal\":{\"name\":\"European Journal of Gastroenterology & Hepatology\",\"volume\":\" \",\"pages\":\"864-874\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Gastroenterology & Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MEG.0000000000002963\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/3/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MEG.0000000000002963","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:非酒精性脂肪性肝病(NAFLD)与多种因素相关,但NAFLD与甲状腺相关生物标志物之间的关系尚不清楚。本研究旨在阐明这种潜在的联系。方法:利用美国国家健康与营养调查(NHANES)的数据,通过多变量logistic回归、亚组分析和相互作用检验,探讨甲状腺相关生物标志物与NAFLD之间可能的关联。然后采用双向孟德尔随机化(MR)方法辅以各种敏感性分析来确定这些关系的因果关系。结果:我们的NHANES分析显示游离三碘甲状腺原氨酸(FT3)水平升高[比值比(OR): 2.59, 95%可信区间(CI): 1.50-4.49]和总三碘甲状腺原氨酸(TT3)水平升高(OR: 2.01, 95% CI: 1.27-3.18)与NAFLD患病率之间存在显著关联。MR结果强化了因果关系,表明NAFLD可能升高FT3 (β: 0.05, 95% CI: 0.01-0.09)和TT3 (β: 0.08, 95% CI: 0.02-0.14)水平。此外,促甲状腺激素(TSH)被证实是NAFLD的独立危险因素(OR: 1.10, 95% CI: 1.04-1.18),特异性MR敏感性分析支持这些结果的稳健性。结论:本研究表明FT3、TT3和甲状腺球蛋白水平的潜在升高与NAFLD相关,同时也确定TSH是NAFLD的危险因素。这些发现强调了常规甲状腺功能监测的重要性,无论是在普通人群,特别是在NAFLD患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Association of free triiodothyronine and total triiodothyronine with nonalcoholic fatty liver disease: from National Health and Nutrition Examination Survey and Mendelian randomization study.

Background: Nonalcoholic fatty liver disease (NAFLD) is associated with multiple factors, yet the relationship between NAFLD and thyroid-related biomarkers remains unclear. This study aims to elucidate this potential linkage.

Methods: Utilizing data from the US National Health and Nutrition Examination Survey (NHANES), we explored the possible associations between thyroid-related biomarkers and NAFLD through multivariable logistic regression, subgroup analysis, and interaction tests. A bidirectional Mendelian randomization (MR) approach complemented by various sensitivity analyses was then employed to ascertain these relationships' causality.

Results: Our NHANES analysis indicated significant associations between elevated levels of free triiodothyronine (FT3) [odds ratio (OR): 2.59, 95% confidence interval (CI): 1.50-4.49] and total triiodothyronine (TT3) (OR: 2.01, 95% CI: 1.27-3.18) with the prevalence of NAFLD. MR findings reinforced the causal relationship, demonstrating that NAFLD may elevate FT3 ( β : 0.05, 95% CI: 0.01-0.09) and TT3 ( β : 0.08, 95% CI: 0.02-0.14) levels. Additionally, thyroid-stimulating hormone (TSH) was confirmed as an independent risk factor for NAFLD (OR: 1.10, 95% CI: 1.04-1.18), with specific MR sensitivity analyses supporting the robustness of these results.

Conclusion: This study indicates potential elevations in FT3, TT3, and thyroglobulin levels associated with NAFLD, while also identifying TSH as a risk factor for NAFLD. These findings underscore the importance of routine thyroid function monitoring both in the general population and particularly in individuals with NAFLD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.40
自引率
4.80%
发文量
269
审稿时长
1 months
期刊介绍: European Journal of Gastroenterology & Hepatology publishes papers reporting original clinical and scientific research which are of a high standard and which contribute to the advancement of knowledge in the field of gastroenterology and hepatology. The journal publishes three types of manuscript: in-depth reviews (by invitation only), full papers and case reports. Manuscripts submitted to the journal will be accepted on the understanding that the author has not previously submitted the paper to another journal or had the material published elsewhere. Authors are asked to disclose any affiliations, including financial, consultant, or institutional associations, that might lead to bias or a conflict of interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信